NORWITT RICHARD ADAM 4

What Happened

• Richard Adam Norwitt, President & CEO and a director of Amphenol (APH), exercised a total of 608,333 underlying derivative awards (options) on 2026-02-12 at an exercise price of $22.37, paying about $13.61M to acquire the shares. He then sold those 608,333 shares in open‑market transactions the same day for gross proceeds of roughly $89.58M. The filings also record the derivative positions as disposed (reporting mechanics for exercised options).

Key Details

• Transaction date: 2026-02-12; Form 4 filed 2026-02-13 (appears timely).
• Options exercised: 515,281 and 93,052 shares at $22.37; total exercise cost ≈ $13,609,930.
• Shares sold: 515,281 at weighted avg $147.27 (range $145.295–$148.77) and 93,052 at weighted avg $147.17 (range $145.240–$148.24); total sale proceeds ≈ $89,577,564.
• Net cash from the sequence (proceeds minus exercise cost) ≈ $75.97M.
• Footnotes: weighted‑average sale price noted; sales executed in multiple trades (price ranges provided); some shares are held through the reporting person’s IRA per filing.
• Shares owned after the reported transactions are not specified in the provided filing excerpt.

Context

• This is a cashless exercise/sale pattern: options were exercised and the resulting shares were sold the same day, which is a common way for insiders to realize option value and cover exercise costs and taxes. Such sales are factual disclosures of transactions and do not by themselves indicate the insider’s longer‑term view of the company.